We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluation of Safety and Performance of the Orbix Breast Lift System

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00774059
Recruitment Status : Withdrawn (No EC approval obtained)
First Posted : October 16, 2008
Last Update Posted : October 12, 2017
Information provided by:
Maastricht University Medical Center

October 15, 2008
October 16, 2008
October 12, 2017
Not Provided
Not Provided
Result after using the breast lift system,recurrence of ptosis. [ Time Frame: one year ]
Same as current
Complete list of historical versions of study NCT00774059 on ClinicalTrials.gov Archive Site
complications [ Time Frame: one year ]
Same as current
Not Provided
Not Provided
Evaluation of Safety and Performance of the Orbix Breast Lift System
Phase 1 Study to Evaluate the Safety and Performance of the Orbix Breast Lift System

The study is using a new breast lift system to complement a breast-lift operation.

In general there will be recurrence of breast-ptosis after a correcting operation.

With this device we want to minimize this recurrence and provide an "internal bra".

Not Provided
Not Provided
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Breast Ptosis
Device: Breast lift system
During a breast operation for ptosis a device is brought into the breast and attached to the ribs, to provide lifting of the breast
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Not Provided
Not Provided

Inclusion Criteria:

1.Female subject between 30-50 years of age 2. Subject is referred for mastopexy(breast lifting)due to one of the following reasons:

  • Breast ptosis grade I or II (minimal invasive)
  • Breast ptosis grade I to IV (open procedure)
  • pseudoptosis following breast reduction surgery 3. subject willing to participate as evidenced by signing the written informed consent 4. Minimal invasive: breast cup size <C

Exclusion Criteria:

  1. Pregnant or lactating women
  2. history of surgical procedures involving the ribs and rib cage
  3. Osteoporosis
  4. breast implants
  5. breast carcinoma
  6. auto-immune disease -
Sexes Eligible for Study: Female
30 Years to 50 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
MEC 08-1-024
Not Provided
Not Provided
Adi Cohen, Orbix Medical
Maastricht University Medical Center
Not Provided
Principal Investigator: Marjoes MP Schuckman, MD Maastricht University Hospital
Study Director: Adi Cohen Orbix medical
Maastricht University Medical Center
October 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP